Breaking News
March 21, 2018 - Hydrogel may accelerate healing of diabetic ulcers
March 21, 2018 - Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
March 21, 2018 - ‘Oh, It Was Nothing’
March 21, 2018 - Herbal drug kratom linked to salmonella illnesses, CDC says
March 21, 2018 - New optical point-of-care device could enhance screening for thyroid nodules
March 21, 2018 - FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
March 21, 2018 - Eosinophilic Esophagitis: Late Manifestation of Allergic March
March 21, 2018 - Signaling pathway involving the Golgi apparatus identified in cells with Huntington’s disease
March 21, 2018 - Quintupling inhaled steroid doses may not benefit children with asthma
March 21, 2018 - Study shows clear connection between cardiovascular fitness in middle age and dementia risk
March 21, 2018 - Premature babies have higher risks of health complications in Bangladesh
March 21, 2018 - Child’s temperament and parenting influence weight gain in babies
March 21, 2018 - Researchers find the heart to be capable of arrhythmia termination after local gene therapy
March 21, 2018 - Inhealthcare to provide digital infrastructure for NHS to help protect people from falls
March 21, 2018 - Flu Season Finally Slowing Down
March 21, 2018 - Mixed Results for Shorter DAPT in ACS Patients
March 21, 2018 - Scientists discover fish scale-derived collagen effective for healing wounds
March 21, 2018 - Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis
March 21, 2018 - Adjuvant AC chemotherapy found to be effective in treating HRD-positive breast cancer patients
March 21, 2018 - Researchers identify new treatment targets for lung diseases using big data
March 21, 2018 - Kids see more women in science than five decades ago
March 21, 2018 - Research shows link between chronic fatigue syndrome and lower thyroid hormone levels
March 21, 2018 - Alzheimer’s disease on the rise
March 21, 2018 - Two Agents Equal as Pretreatment for Adrenal Tumor Surgery
March 21, 2018 - ‘Icebreaker’ protein opens genome for T cell development, researchers find
March 21, 2018 - Women in medicine shout #Metoo about sexual harassment at work
March 21, 2018 - Mother’s pre-pregnancy waist size may be linked to child’s autism risk
March 21, 2018 - Second hand marijuana smoke can cause serious damage
March 21, 2018 - International study shows benefits of using MRI at the start of prostate cancer diagnosis
March 20, 2018 - Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
March 20, 2018 - ECG Patch Ups At-Home Afib Diagnosis in mSToPS Trial
March 20, 2018 - ROS-scavenging nanozymes for anti-inflammation therapeutics
March 20, 2018 - Genomics England announces appointment of global genomics pioneer as first CEO
March 20, 2018 - Test flight at German Aerospace Center in Cologne demonstrates functionality of deficopter
March 20, 2018 - Music therapy helps treat combat-related psychological injuries in military personnel
March 20, 2018 - Innovative psychotherapeutic treatment protocol for obsessive-compulsive disorders
March 20, 2018 - Weight loss after lap-band surgery alleviates arthritic knee pain
March 20, 2018 - New diabetes drug may help obese people shed body weight
March 20, 2018 - Novel Peanut OIT a Winner in Phase III Trial
March 20, 2018 - Can gene therapy be harnessed to fight the AIDS virus?
March 20, 2018 - Education and academic achievement can lessen effects of child abuse, neglect
March 20, 2018 - Researchers develop new algorithm to make CPR more effective
March 20, 2018 - Diabetes medication reduces chance of late miscarriage, premature birth among women with PCOS
March 20, 2018 - SSRIs may be more effective option for treating anxious youth, UC research shows
March 20, 2018 - Antibiotics could benefit women suffering from chronic bladder pain
March 20, 2018 - Health Highlights: March 16, 2018
March 20, 2018 - Interventional Radiology Has a Problem of ‘Unseen’ Value
March 20, 2018 - Antibodies show effectiveness for HIV prevention and promise for treatment and cure
March 20, 2018 - New 3-D-printed technology will improve radiology training
March 20, 2018 - New study identifies key role for particular gene in 16p11.2 deletion syndrome
March 20, 2018 - Red and processed meat increase the risk of liver disease
March 20, 2018 - 50% of Australians do not brush teeth twice a day
March 20, 2018 - American Gene Technologies receives second immuno-oncology patent
March 20, 2018 - Study finds no link between long-term violent video game play and adult aggression
March 20, 2018 - Weight loss surgery widely underutilized among young patients with severe obesity
March 20, 2018 - Scientists uncover new answers to cell aging in children with rare, fatal disease
March 20, 2018 - The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the ‘Lab of the Future’
March 20, 2018 - Morning Break: Psychopathic Thought; Americans Flout Zzz’s; Farm to Pharma
March 20, 2018 - Perceptions of old age change as we age
March 20, 2018 - New standards for public involvement in research launched across the UK
March 20, 2018 - Whole Genome Sequencing used as diagnostic solution for TB
March 20, 2018 - Researchers show how two cancer genes work together to trigger leukemia
March 20, 2018 - Scientists discover basic molecular mechanism that helps understand how ALS works
March 20, 2018 - Multi-center study to evaluate promising new intervention for upper limb dysfunction after SCI
March 20, 2018 - Researchers develop technology to program DNA for delivering cancer drugs
March 20, 2018 - Northwestern scientists bring precision medicine to rheumatoid arthritis
March 20, 2018 - Research suggests possible link between heading a soccer ball and brain imbalance
March 20, 2018 - Robocall increases diabetic retinopathy screening rates among poor minorities
March 20, 2018 - INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Infantile Spasms
March 20, 2018 - Little Talk Between Docs and Patients Pre-PSA Screen
March 20, 2018 - Women GPs bring remote care to rural Pakistan
March 20, 2018 - Adults skipping vaccines may miss out on effective new shingles shot
March 20, 2018 - Suppressing emotions appears to reduce negative memories
March 20, 2018 - Epidural stimulation can safely, effectively normalize blood pressure in patients with SCI
March 20, 2018 - ‘Fast track’ project shows promising results in cancer whole genome analyses
March 20, 2018 - Advanced insulin pump system can also manage type 1 diabetes in children, study shows
March 20, 2018 - Flu risk less on flights if in a window seat finds study
March 20, 2018 - Sarepta Therapeutics Announces Plan to Submit a New Drug Application (NDA) for Accelerated Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53
March 20, 2018 - Post-Transplant Fatty Liver Disease on the Rise
March 20, 2018 - New mutation linked to ovarian cancer can be passed down through dad
Phillip Sharp Pays it Forward

Phillip Sharp Pays it Forward

image_pdfDownload PDFimage_print

In 1989, Phillip A. Sharp, PhD, thought that his shot at a Nobel Prize might have passed after Thomas R. Cech, PhD, won the Chemistry prize that year (with Sidney Altman, PhD) for discovery of the catalytic properties of RNA.

In an exclusive interview with MedPage Today, Sharp recalled that he and Richard J. Roberts, PhD, independently discovered gene splitting and RNA splicing when they were at Cold Spring Harbor Laboratory in 1977, but a few years later Cech found an intron in Tetrahymena, and then discovered that the intron was self-spliced.

“Tom and I had shared a number of prizes including the Lasker Award [in 1988], and so when he got the Nobel with Altman in chemistry I sort of assumed at that level that was going to be the recognition in the field of RNA splicing,” he said.

But he was pleasantly mistaken because on Columbus Day in 1993, Sharp was awakened at 6 am by the ringing of his telephone. He was sleeping in that day because the holiday was a big deal in Massachusetts and he had intended to go into work a little later than usual.

“I didn’t expect anyone to call at that hour in the morning, but then I started to tingle a little bit, and when I picked it up it was a Swedish colleague telling me that I had been selected for the Nobel in Physiology or Medicine, and the next thing out of his mouth was did I have Rich Roberts’ telephone number.”

With a chuckle, Sharp recalled that he was befuddled at the time and in no condition to look up anything, so he told his colleague that he would have to find the number some other way since Roberts — his co-recipient — had recently relocated.

And so began a very surrealistic day, according to the molecular biologist and geneticist who is Institute Professor at the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology and whose discovery of “discontinuous genes” in mammalian cells fundamentally changed the understanding of gene structure.

Sharp said that 10 minutes after the call his doorbell began chiming, and he sent his wife Ann to see who was there. It turned out to be a photographer who lived in the vicinity and monitored Nobel announcements in the Cambridge-area academic haven.

He asked her to wait until he showered and dressed before the photo session, and then at 7 am he learned that MIT wanted him to be available for a 10 am press conference, and to deliver a lecture about his discovery that afternoon for the entire MIT body.

The day continued as a whirlwind, including lunch with his dean, a champagne celebration with the biology department, and then an evening neighborhood party that lasted until the wee hours, Sharp said.

“It was one of the happiest times I ever had in my life.” He used his prize money to buy an old Federal-style house several blocks from his Victorian home in Newton, Massachusetts.

The Nobel and the Lasker are hardly the only honors bestowed on Sharp, a member of the U.S. National Academies and Britain’s Royal Society as well as a recipient of General Motors’ Alfred A. Sloan Prize for Cancer Research. A more personal honor was having his former middle school in Butler, Kentucky, named for him.

He shared with MedPage Today what these testaments have meant and how he’s been paying it forward in a number of ways including his relationship with the Entertainment Industry Foundation’s (EIF) Stand Up To Cancer (SU2C) initiative. An EIF communications official also listened to the phone interview.

Sharp was born in the rural northern hill country of Kentucky and raised on his family’s farm. He grew tobacco and raised cattle to help pay his tuition at Union College in Barbourville, Kentucky, and then received his doctorate in physical chemistry from the University of Illinois. He did his post-doctoral work at the California Institute of Technology, followed by another post-doc at Cold Spring Harbor where his mentor was Nobel laureate James D. Watson, PhD.

In 1974 Sharp was invited to join MIT’s Center for Cancer Research (now the Koch Institute) by yet another Nobelist, Salvador Luria, MD; he served as the center’s director from 1985 to 1991, before being named head of the Department of Biology, a position he held for 8 years. He was founding director of the McGovern Institute from 2000 to 2004.

He also helped found biotech companies Biogen in 1978, Alnylam Pharmaceuticals in 2002, and Magen BioSciences in 2006.

“I left the board of Biogen about 6 years ago after 29 years following a call for change by dissident stockholder Carl Icahn. I said if you want change, then I should be a source of it as well as others,” he told MedPage Today.

Today, Sharp’s MIT lab has about 10 people, and he’s involved on several corporate boards, as well as chairing Stand Up To Cancer’s Scientific Advisory Council.

Sharp said that for those in academia, receiving the Nobel is similar to being “anointed or ordained.”

“If you’re seeking a committee appointment or trying to impress people that your research is significant, and there’s a list of 10 people, it’s the laureate who will be chosen.”

He confided that he was only tempted once to leave MIT for industry and that was when Biogen moved to Cambridge.

“MIT was comfortable with the arrangement, but at the end of the day when I considered my lifestyle and interests, I realized I wanted to stay and could actually do more for Biogen there.”

Now, 43 years later he’s still at the Institute and has continued the tradition of research discussions among researchers and their post-docs and graduate students every Wednesday at noon.

Sharp said that back in the 1970s, he, Robert Weinberg, PhD, and 1975 Nobel laureate David Baltimore, PhD, began the meetings so their respective labs could learn more about each other’s ongoing work, and the junior researchers are encouraged to present.

But it’s been his role as chair of Stand Up To Cancer’s Scientific Advisory Committee that has given him additional public recognition during the last several years, including, he said, providing him some “street presence” beyond the scientific community.

He said that about 10 years ago he was invited to an American Association for Cancer Research meeting without having a hint about its purpose, and learned about a new initiative called Stand Up To Cancer that wanted to use scientific collaboration to help change the rate of progress in cancer research.

AACR was to be Stand Up’s scientific partner and Sharp was asked to be chair of its advisory committee.

“Many things ran through my mind,” he said. “The visibility of these people [the Hollywood establishment] was going to be part of the face of cancer research in this country, and the message of collaboration and focus on engaging patients now was a message that I thought the scientific community needed.”

“However, although they were very earnest and excited about what they were going to do, I thought they [Stand Up’s founders] were quite naïve about what had already been done and how difficult cancer is to treat.”

But that’s where his having been “ordained” could play a role, Sharp told MedPage Today, and he thought he could help make Stand Up’s dreams come true.

“I didn’t need another job, but I decided to do it and it’s worked out much better than I ever hoped.”

For a basic scientist Sharp has had a long history collaborating and focusing on the patient. When he helped start Biogen, he realized how impactful new science could be when translated into treatment for people, and has championed making bench scientists more sensitive to patients’ needs.

Much of this has been demonstrated in the creation of numerous SU2C “dream teams,” composed of clinical and basic researchers from multiple institutions who have to tackle specific cancer challenges with an endpoint related to patients. He has also created a few “shotgun marriages” between researchers who might not have volunteered to work together but whose collaborative efforts have exceeded what they could do independently.

In recognition of his accomplishments, SU2C established the Phillip A. Sharp Innovation in Collaboration Awards in 2014, to foster collaboration among members of Stand Up’s scientific community encouraging them to work together with researchers with whom they have not collaborated.

Another way that Sharp is giving back is through two scholarships established by him and his former schoolteacher wife at his high school that provides $6,000 a year for four years to one male and one female student if they attend college and live on campus. “In that area of the country it’s actually affirmative action for males,” he noted.


Tagged with:

About author

Related Articles